Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
International Urology and Nephrology
|
March 2, 2025
Observation of the efficacy and safety of obinutuzumab in the treatment of refractory idiopathic membranous nephropathy
Luyao Li, Sha Wang, Mingming Wei, et al.
Journal of Medicinal Chemistry
|
February 3, 2025
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer
Yubo Wang, Mengmeng Wang, Lan Ma, et al.
Journal of Medicinal Chemistry
|
October 25, 2021
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
Sheng Cao, Lan Ma, Yulin Liu, et al.
BMC Cancer
|
November 14, 2021
MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer
Hongli Pan, Zhenhua Pan, Fengjie Guo, et al.
European Journal of Medicinal Chemistry
|
February 3, 2023
Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells
Yulin Liu, Yujiao Wei, Xuan Wang, et al.
International Journal of Biological Macromolecules
|
December 26, 2024
Identification of chemical inhibitors targeting long noncoding RNA through gene signature-based high throughput screening
Jun An, Huili Wang, Mingming Wei, et al.
Bioorganic Chemistry
|
April 11, 2021
In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
Yubo Wang, Yuanyuan Zhou, Sheng Cao, et al.
Science Translational Medicine
|
September 24, 2025
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts
Lan Ma, Kun Zhang, Zixuan Zhang, et al.
Cancer Letters
|
May 26, 2024
Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3
Yulin Liu, Liting Zheng, Ying Li, et al.
European Journal of Medicinal Chemistry
|
April 16, 2024
Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor
Yubo Wang, Yulin Liu, Yan Zhang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
International Urology and Nephrology
|
March 2, 2025
Observation of the efficacy and safety of obinutuzumab in the treatment of refractory idiopathic membranous nephropathy
Luyao Li, Sha Wang, Mingming Wei, et al.
Journal of Medicinal Chemistry
|
February 3, 2025
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer
Yubo Wang, Mengmeng Wang, Lan Ma, et al.
Journal of Medicinal Chemistry
|
October 25, 2021
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
Sheng Cao, Lan Ma, Yulin Liu, et al.
BMC Cancer
|
November 14, 2021
MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer
Hongli Pan, Zhenhua Pan, Fengjie Guo, et al.
European Journal of Medicinal Chemistry
|
February 3, 2023
Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells
Yulin Liu, Yujiao Wei, Xuan Wang, et al.
International Journal of Biological Macromolecules
|
December 26, 2024
Identification of chemical inhibitors targeting long noncoding RNA through gene signature-based high throughput screening
Jun An, Huili Wang, Mingming Wei, et al.
Bioorganic Chemistry
|
April 11, 2021
In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
Yubo Wang, Yuanyuan Zhou, Sheng Cao, et al.
Science Translational Medicine
|
September 24, 2025
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts
Lan Ma, Kun Zhang, Zixuan Zhang, et al.
Cancer Letters
|
May 26, 2024
Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3
Yulin Liu, Liting Zheng, Ying Li, et al.
European Journal of Medicinal Chemistry
|
April 16, 2024
Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor
Yubo Wang, Yulin Liu, Yan Zhang, et al.
Page
of 7